Rosenqvist, Mari
Wilson, Darius Cameron
Tegnér, Lena
Bengtsson-Toni, Maria
Peyman, Marjaneh
del Castillo, Juan Gonzalez
Saeed, Kordo
Melander, Olle
Article History
Received: 26 March 2019
Accepted: 4 April 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: The study was approved by the Regional Ethical Review Board at Lund University, Sweden (2013/635), and was conducted in accordance with the Helsinki Declaration. Informed consent was obtained from all patients or their next of kin.
: No individual participant data is reported that would require consent to publish from the participant (or legal parent or guardian for children).
: All authors have provided information on potential conflicts of interests directly or indirectly related to the work submitted in the journal’s disclosure forms. At the time of initial analysis, interpretation and writing, DCW was an employee of BRAHMS GmbH, which holds patent rights on the procalcitonin and mid-regional proadrenomedullin assay. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.